(Q47236316)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Angelo De Milito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Francesca Chiodi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Ann Atlas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Tran Thi Thanh Ha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Anna Lindström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Annette Alaeus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

345-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

Immune activation is a dominant factor in the pathogenesis of African AIDS

21 January 2018

1 reference

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

21 January 2018

1 reference

Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.

21 January 2018

1 reference

Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects

21 January 2018

1 reference

Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus.

21 January 2018

1 reference

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

21 January 2018

1 reference

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

21 January 2018

1 reference

Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort

21 January 2018

1 reference

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

21 January 2018

1 reference

Human immunodeficiency virus type 1 subtypes differ in disease progression

21 January 2018

1 reference

Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers

21 January 2018

1 reference

Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function

21 January 2018

1 reference

Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial

21 January 2018

1 reference

Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program

21 January 2018

1 reference

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance

21 January 2018

1 reference

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma

21 January 2018

1 reference

Clinical disease associated with HIV-1 subtype B‚ _and E infection among 2104 patients in Thailand

21 January 2018

1 reference

The puzzle of HIV-1 subtypes in Africa

21 January 2018

1 reference

Control of lymphocyte function through CD27–CD70 interactions

21 January 2018

1 reference

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.20006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748056%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference